Our catalogue of inflammation models recapitulates key clinical and pathological features of human disease, forming an integrated platform for preclinical drug development.
In most cases, we can initiate preclinical studies on our inflammation platform in as little as fourteen days. Promising agents can be quickly identified in vivo and advanced with confidence in their clinical efficacy.
![]() ![]() |
![]() ![]() |
![]() In Vivo Models ![]() |
Tell us how we can help